March 25, 2025 - 00:43

SOUTH SAN FRANCISCO, Calif., March 24, 2025—Quince Therapeutics, Inc., a late-stage biotechnology company focused on leveraging the potential of patients' own biology to address rare diseases, has announced significant updates regarding its development pipeline alongside its financial results for the fiscal year ending December 31, 2024.
The company has made notable strides in advancing its therapeutic candidates, emphasizing its commitment to innovation in the treatment of conditions that currently lack effective solutions. Key milestones achieved over the past year include successful clinical trials and the initiation of new studies aimed at expanding its therapeutic offerings.
Financially, Quince Therapeutics reported a robust performance, reflecting the investments made in research and development. The company is optimistic about its future prospects, as it continues to explore partnerships and collaborations that could enhance its market position. Overall, the updates signify a promising trajectory for Quince Therapeutics as it works to improve the lives of patients with rare diseases.
November 1, 2025 - 02:47
Mike Tyson Launches New Initiative to Aid SNAP Recipients Amid Government ShutdownMike Tyson has announced his latest business venture, ChaChing’s Price Fighter, with the aim of providing support to the 42 million Americans affected by impending reductions in SNAP benefits....
October 31, 2025 - 10:37
Jack's Donuts Owner Files for Bankruptcy ProtectionThree businesses associated with Jack’s Donuts, owned by CEO Jack “Lee” Marcum III, have recently filed for Chapter 11 bankruptcy protection. The filings reveal staggering financial...
October 30, 2025 - 22:21
Amazon Reports 38% Profit Increase Amid Strong SalesIn a surprising turn of events, the tech giant has announced a remarkable 38% increase in profits, attributed to robust performance in both its consumer and cloud segments. The company`s latest...
October 30, 2025 - 05:08
US Nuclear Weapons Tests May Resume After Three DecadesThe last time the US tested a nuclear weapon was in 1992, when Congress pushed to halt such trials in the wake of the Cold War. However, recent developments indicate a potential shift in this...